Primary |
Drug Use For Unknown Indication |
44.4% |
Sinusitis |
22.2% |
Antibiotic Prophylaxis |
11.1% |
Endocarditis |
11.1% |
Prophylaxis |
11.1% |
|
Cardio-respiratory Arrest |
14.3% |
Rash Erythematous |
14.3% |
Rash Generalised |
14.3% |
Transaminases Increased |
14.3% |
Type I Hypersensitivity |
14.3% |
Urticaria |
14.3% |
Weight Decreased |
14.3% |
|
Secondary |
Drug Use For Unknown Indication |
36.4% |
Induction Of Anaesthesia |
18.2% |
Wound Infection |
12.7% |
Acquired Immunodeficiency Syndrome |
5.5% |
Cellulitis |
3.6% |
Mental Disorder |
3.6% |
Psychotic Disorder |
3.6% |
Computerised Tomogram |
1.8% |
Hypercholesterolaemia |
1.8% |
Intravenous Catheter Management |
1.8% |
Mitral Valve Replacement |
1.8% |
Nephrectomy |
1.8% |
Prophylaxis |
1.8% |
Respiratory Tract Infection |
1.8% |
Thrombosis Prophylaxis |
1.8% |
Urinary Tract Infection |
1.8% |
|
Urticaria |
15.4% |
White Blood Cells Urine Positive |
15.4% |
Anaphylactic Shock |
7.7% |
Cardiac Arrest |
7.7% |
Jaundice |
7.7% |
Pruritus |
7.7% |
Purpura |
7.7% |
Small Intestinal Obstruction |
7.7% |
Tachypnoea |
7.7% |
Therapeutic Response Decreased |
7.7% |
White Blood Cell Count Increased |
7.7% |
|
Concomitant |
Product Used For Unknown Indication |
36.5% |
Drug Use For Unknown Indication |
10.7% |
Non-small Cell Lung Cancer |
6.1% |
Hypertension |
5.3% |
Osteoporosis |
4.9% |
Coronary Artery Bypass |
4.9% |
Pain |
4.8% |
Systemic Lupus Erythematosus |
3.5% |
Thrombosis Prophylaxis |
3.1% |
Infection Prophylaxis |
2.6% |
Sedation |
2.4% |
Pain Prophylaxis |
2.0% |
Prophylaxis |
1.9% |
Contraception |
1.8% |
Nausea |
1.8% |
Anaesthesia |
1.7% |
Cholecystectomy |
1.7% |
Aortic Valve Replacement |
1.4% |
Constipation |
1.4% |
Catheterisation Cardiac |
1.4% |
|
Wound Infection Staphylococcal |
12.9% |
Pain |
11.0% |
Vomiting |
9.8% |
Injury |
8.0% |
Unevaluable Event |
6.7% |
Fear |
5.5% |
Renal Failure |
5.5% |
Weight Decreased |
4.9% |
Anhedonia |
4.3% |
Anxiety |
4.3% |
Depression |
3.7% |
Emotional Distress |
3.1% |
Vertebral Injury |
3.1% |
Walking Aid User |
3.1% |
Multi-organ Failure |
2.5% |
Renal Impairment |
2.5% |
Renal Injury |
2.5% |
Stress |
2.5% |
Upper Respiratory Tract Infection |
2.5% |
Myocardial Infarction |
1.8% |
|
Interacting |
Thrombosis Prophylaxis |
100.0% |
|
Postoperative Fever |
100.0% |
|